MS546 FENOFIBRATE REDUCES PERIPHERAL NEUROPATHY IN TYPE 2 DIABETES: THE FENOFIBRATE INTERVENTION AND EVENT LOWERING IN DIABETES (FIELD) STUDY

Atherosclerosis Supplements ◽

10.1016/s1567-5688(10)71046-1 ◽

2010 ◽

Vol 11 (2) ◽

pp. 219-220

Author(s):

K. Rajamani ◽

M. Donoghoe ◽

L. Li ◽

R.-D. Ting ◽

P. Colman ◽

...

Keyword(s):

Type 2 Diabetes ◽

Peripheral Neuropathy ◽

Field Study ◽

Fenofibrate Intervention

Download Full-text

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

Diabetologia ◽

10.1007/s00125-010-1951-1 ◽

2010 ◽

Vol 54 (2) ◽

pp. 280-290 ◽

Author(s):

T. M. E. Davis ◽

◽

R. Ting ◽

J. D. Best ◽

M. W. Donoghoe ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Renal Function ◽

Field Study ◽

Fenofibrate Intervention

Download Full-text

Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

European Heart Journal ◽

10.1093/eurheartj/ehp377 ◽

2009 ◽

Vol 31 (1) ◽

pp. 92-99 ◽

Author(s):

D. C. Burgess ◽

D. Hunt ◽

L. Li ◽

D. Zannino ◽

E. Williamson ◽

...

Keyword(s):

Myocardial Infarction ◽

Type 2 Diabetes ◽

Field Study ◽

Silent Myocardial Infarction ◽

Fenofibrate Intervention

Download Full-text

Risk Predictors of Lower-limb Amputation in Patients with Type 2 Diabetes Mellitus in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

Heart Lung and Circulation ◽

10.1016/j.hlc.2011.05.049 ◽

2011 ◽

Vol 20 ◽

pp. S20

Author(s):

K. Rajamani ◽

L. Li ◽

J. Best ◽

M. Voysey ◽

R. Ting ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Field Study ◽

Lower Limb Amputation ◽

Limb Amputation ◽

Risk Predictors ◽

Fenofibrate Intervention

Download Full-text

Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Yearbook of Endocrinology ◽

10.1016/s0084-3741(10)79552-4 ◽

2010 ◽

Vol 2010 ◽

pp. 53-54

Author(s):

P.P. Toth

Keyword(s):

Myocardial Infarction ◽

Type 2 Diabetes ◽

Field Study ◽

Silent Myocardial Infarction ◽

Fenofibrate Intervention

Download Full-text

Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Yearbook of Medicine ◽

10.1016/s0084-3873(10)79811-4 ◽

2010 ◽

Vol 2010 ◽

pp. 514-515

Author(s):

P.P. Toth

Keyword(s):

Myocardial Infarction ◽

Type 2 Diabetes ◽

Field Study ◽

Silent Myocardial Infarction ◽

Fenofibrate Intervention

Download Full-text

Faculty Opinions recommendation of Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1159891.621322 ◽

2009 ◽

Author(s):

Timothy Lyons ◽

Madona Azar

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Metabolic Syndrome ◽

Field Study ◽

Disease Risk ◽

Cardiovascular Disease Risk ◽

The Metabolic Syndrome ◽

Fenofibrate Treatment ◽

Fenofibrate Intervention

Download Full-text

Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Diabetologia ◽

10.1007/s00125-014-3344-3 ◽

2014 ◽

Vol 57 (11) ◽

pp. 2296-2303 ◽

Author(s):

Michael C. d’Emden ◽

◽

Alicia J. Jenkins ◽

Liping Li ◽

Diana Zannino ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Field Study ◽

Cardiovascular Disease In Women ◽

Fenofibrate Intervention

Download Full-text

Erratum to: Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Diabetologia ◽

10.1007/s00125-015-3693-6 ◽

2015 ◽

Vol 58 (9) ◽

pp. 2200-2200

Author(s):

Michael C. d’Emden ◽

◽

Alicia J. Jenkins ◽

Liping Li ◽

Diana Zannino ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Field Study ◽

Cardiovascular Disease In Women ◽

Fenofibrate Intervention

Download Full-text

Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

10.1016/j.metabol.2015.12.008 ◽

2016 ◽

Vol 65 (5) ◽

pp. 783-793 ◽

Author(s):

Kathryn H. Williams ◽

David R. Sullivan ◽

Geoffrey C. Nicholson ◽

Jacob George ◽

Alicia J. Jenkins ◽

...

Keyword(s):

Type 2 Diabetes ◽

Field Study ◽

Alanine Aminotransferase ◽

All Cause Mortality ◽

Glutamyl Transferase ◽

Fenofibrate Intervention

Download Full-text

Faculty Opinions recommendation of Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8281957.8713055 ◽

2011 ◽

Author(s):

Om P Ganda

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Renal Function ◽

Field Study ◽

Fenofibrate Intervention

Download Full-text